Stock quote - Summary

Advanced Oncotherapy
AVO: 53.50 +1.50 ( +2.88 %) delayed: 17:07PM
Bid price 52.00 High price 55.00
Ask price 55.00 Low price 52.50
Open price 53.00 Spread 5.45%
Prev close 53.50 Volume 135,162

Advanced Oncotherapy - Share price charts

Intraday
Historic - 6 months

Advanced Advanced Oncotherapy charts >

Advanced Oncotherapy - Share price information
Name Advanced Oncotherapy Epic AVO
Activities Advanced Oncotherapy plc (formerly CareCapital Group plc) is a provider of particle therapy with protons that harnesses the best in modern technology. Advanced Oncotherapy's team ADAM, based in Geneva, focuses on the development of a proprietary proton accelerator called Linac Image Guided Hadron Technology (LIGHT). LIGHT's compact configuration delivers proton beams in a way that facilitates greater precision and electronic control which is not achievable with older technologies. Advanced Oncotherapy will offer healthcare providers affordable systems that will enable them to treat cancer with an innovative technology as well as lower treatment related side effects. Advanced Oncotherapy continually monitors the market for any emerging improvements in delivering proton therapy and actively seeks working relationships with providers of these innovative technologies. Through these relationships, the Company will remain the prime provider of an innovative and cost-effective system for particle therapy with protons. ISIN GB00BD6SX109
Latest Share Price (p) 53.50 Net Gearing (%) 36.75
Market Capitalisation (pm) 80.93 Gross Gearing (%) 36.87
Shares in issue (m) 155.63 Debt Ratio 0.00
P/E Ratio -2.96 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.58
Dividend Yield (%) 0.00 Price to book value 2.82
Dividend Cover 0.00 ROCE (%) -57.54
Earning per share (p) -17.55 EPS Growth (%) -3.17
52-week high / low (p) 63.50 / 9.75 DPS Growth (%) n/a
Advanced Oncotherapy - Broker views
Date Broker Recommendation Price Old target price New target price Notes
27 Feb Beaufort Securities Hold - - Downgrades
25 Jan Beaufort Securities Speculative Buy - - Retains
24 Jan Beaufort Securities Speculative Buy - - Retains
23 Dec Beaufort Securities Speculative Buy - - Retains
16 Dec Beaufort Securities Speculative Buy - - Retains

More Advanced Oncotherapy broker views >

Advanced Oncotherapy - Director deals
Date Director Type Volume / Price Trade value
12 Jan 2018 Dr Enrico Vanni Buy 40,000 @ 54.50p £21,800.00
01 Aug 2017 Dr Enrico Vanni Buy 100,000 @ 17.75p £17,750.00
15 May 2017 Prof Steve Myers Buy 400,000 @ 26.00p £104,000.00
11 May 2017 Prof Christopher Nutting Buy 202,500 @ 24.67p £49,956.75
26 Apr 2017 Dr Mike Sinclair Buy 200,000 @ 30.44p £60,880.00

More Advanced Oncotherapy director deals >

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.